Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Nifty Pharma index drops 3% as US tariff fears hit Sun Pharma, peers
A Bloomberg report indicated that the Trump administration is planning tariffs on pharmaceutical companies that have not entered into agreements to ensure lower drug prices in the US.
Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.
Top Gainers & Losers on Mar 12: Piramal Pharma, Tejas Networks, Apollo Tyres, PG Electroplast among top losers
The Indian stock market extended its losses on March 12, with the Nifty 50 and Sensex down 1% and 1.08%. Tensions in the Middle East affected investor sentiment, particularly impacting auto stocks, while broader markets showed some positive movement.
Sensex tanks 1,342 pts, Nifty below 23,900 as geopolitical tensions weigh
The key equity benchmarks ended with sharp losses on Wednesday, dragged down by selling in select heavyweights. Geopolitical tensions in the Middle East, particularly the ongoing US-Iran conflict, continued to weigh on market sentiment. Despite earlier expectations that the conflict might end soon, the situation in the region remains tense. Sustained selling by overseas investors over the past several sessions also pressured the market, while the rupee weakened further against the dollar. The Nifty ended below the 23,900 level, led by declines in auto, private bank and financial stocks. However, pharma and healthcare stocks bucked the broader weak market trend.
Sensex nosedives 1,342 pts; Nifty sinks below 23,900 level; VIX jumps 11.41%
Nifty ended below the 23,900 level. Auto, private bank and financial services shares declined, while pharma, oil & gas shares and healthcare shares advanced.
Nifty Pharma index hits 52-week high; Ipca, Aurobindo rally up to 4%
In the past one month, the Nifty Pharma index has rallied 4.5 per cent, as against 7.8 per cent decline in the benchmark Nifty 50.
Sensex Today Trades Higher | Nifty Above 24,100 | Natco Pharma Up 4% - Equitymaster
Sensex Today Trades Higher | Nifty Above 24,100 | Natco Pharma Up 4%Equitymaster
Today's Market: Sensex Today Trades Higher | Nifty Above 24,100 | Natco Pharma Up 4% - Indian Stock Market News - Equitymaster
Today's Market: Sensex Today Trades Higher | Nifty Above 24,100 | Natco Pharma Up 4% - Indian Stock Market NewsEquitymaster
PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.
Market Trading Guide: Apollo Pipes among 3 stock recommendations for Tuesday
Sensex and Nifty plunged nearly 2% as rising crude oil prices, weak global cues and escalating West Asia tensions triggered heavy selling. Foreign fund outflows and a weaker rupee added pressure. Analysts recommend Apollo Pipes, Aurobindo Pharma and Tata Steel for potential short-term gains.
Market ends sideways; Nifty settles near 25,500 level; VIX drops 3.15%
Nifty ended near the 25,500 level. Pharma, PSU bank and oil & gas shares advanced, while media, FMCG and financial services stocks declined.
Top Gainers & Losers on Feb 26: Tejas Networks, KSB, Mankind Pharma, Tata Motors, Finolex Cables among top gainers
The Indian stock market remained largely unchanged on February 26, with the Nifty 50 up 0.06% at 25,496 and the S&P BSE Sensex flat at 82,248. Broader markets showed mixed results, while US stocks rallied on Nvidia's strong earnings, boosting Asian markets as well.